SNCA and Parkinson disease: On the other hand, Kabaria and colleagues [19] have found that rs10024743in the SNCA 3′ UTR lowers the miR-34b-mediated repression of the protein and suggested that down-regulation of miR-34b and miR-34c in the brain can increase α-synuclein expression, possibly contributing to PD pathogenesis.